APA (7th ed.) Citation

Zhang, W., Li, Y., Li, C., & Huang, Q. (2025). Integrated single-cell and bulk transcriptomic profiling reveals cancer-associated fibroblast heterogeneity in glioblastoma and establishes a clinically actionable prognostic model and preliminary experimental validation. Hereditas, 162(1), 1. https://doi.org/10.1186/s41065-025-00548-8

Chicago Style (17th ed.) Citation

Zhang, Wenhua, Yaxiong Li, Conghui Li, and Qiang Huang. "Integrated Single-cell and Bulk Transcriptomic Profiling Reveals Cancer-associated Fibroblast Heterogeneity in Glioblastoma and Establishes a Clinically Actionable Prognostic Model and Preliminary Experimental Validation." Hereditas 162, no. 1 (2025): 1. https://doi.org/10.1186/s41065-025-00548-8.

MLA (9th ed.) Citation

Zhang, Wenhua, et al. "Integrated Single-cell and Bulk Transcriptomic Profiling Reveals Cancer-associated Fibroblast Heterogeneity in Glioblastoma and Establishes a Clinically Actionable Prognostic Model and Preliminary Experimental Validation." Hereditas, vol. 162, no. 1, 2025, p. 1, https://doi.org/10.1186/s41065-025-00548-8.